Androgen deprivation therapy and the risk of iron-deficiency anaemia among patients with prostate cancer: a population-based cohort study.
Fang-Jen WuI-Hsun LiWu-Chien ChienJui-Hu ShihYi-Chun LinChin-Min ChuangYih-Dih ChengLi-Ting KaoPublished in: BMJ open (2020)
Compared with its non-use among patients with prostate cancer, ADT use was associated with a higher risk of IDA.